Found 5 matching trials
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
PHASE3The study aims to assess the safety and efficacy of Viaskin Peanut to induc...
Location
University of Arizona Health Science
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
PHASE1The purpose of this phase 1b study is to evaluate the safety and tolerabili...
Location
Arkansas Children's Hospital
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
PHASE3The primary purpose of this study is to assess the efficacy and safety of d...
Status
Active Not Recruiting
Location
DBV Investigative Site
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
PHASE2Food allergy occurs when the immune system reacts against foods. The immune...
Location
Arkansas Children's Hospital
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
PHASE2The objectives of this dose-finding study for the treatment of peanut aller...
Location
University of California, Rady Childrens Hospital